You must be signed in to use this feature.


2016 STO Fellows' Forum (STOFF)

The Society for Translational Oncology Fellows' Forum (STOFF) is a 3-day intensive forum that brings together fellows and junior faculty within 5 years of training completion from the leading medical, surgical, and radiation oncology subspecialty fellowships to educate rising stars in translational cancer research.

STOFF 2016

December 8 - 11, 2016
Cary, North Carolina
Program Brochure (PDF)

Key Meeting Topics

Phase I Clinical Trials: Hypothesis Testing
Immune Checkpoint Inhibition in Advanced Cancer
Oncology Drug Development: A Regulatory Perspective

Presentation Summaries

Oncology Drug Development: Honest Views from an Academic Bernardo Goulart, MD, MS Summary (PDF)

Precision Medicine: Myth or RealityBruce A. Chabner, MD Summary (PDF)

Phase 1 Clinical Trials: Hypothesis Testing Keith T. Flaherty, MDSummary (PDF)

New Drug Development in 2016: Progress, Challenges, and Prices Thomas G. Roberts, Jr., MD, MSoc SciSummary (PDF)

National Cancer Moonshot – Blue Ribbon Panel ® Deborah Mayer, PhD, RN, AOCN, FAANSummary (PDF)

Data Sharing, Research Parasites, and the Korean AlphabetGeoffrey Kim, MDSummary (PDF)

The Cancer Genome Atlas (TCGA)William Kim, MDSummary (PDF)

Guidelines for Good Scientific PracticeMark W. Duncan, PhDSummary (PDF)

Immune Checkpoint Inhibition in Advanced CancerMichael Postow, MDSummary (PDF)

PharmacogenomicsPeter H. O’Donnell, MDSummary (PDF)

Receptor-Associated Kinase Inhibitor / Intracellular Resistance PathwaysJeffrey Engelman, MD, PhD Summary (PDF)

How to Write a GrantKeith T. Flaherty, MDSummary (PDF)

Oncology Drug Development: A Regulatory PerspectiveTatiana Prowell, MDSummary (PDF)

Summaries were created from the proceedings of the Society for Translational Oncology Fellows’ Forum held on December 8-11, 2016 in Cary, NC.

The Society for Translational Oncology gratefully acknowledges educational grants in partial support of this activity from: